EUVIMEDEUVIMED entdecken
Crossref

Clinical severity and associated complications in pediatric patients with Guillain-Barré syndrome

Ángel Solana-Rojas, Luis M. García-Melo, María D. Reyes-Varela, Juan F. Díaz-Sotelo, Alfredo Cruz-Sánchez, Juan C. Pérez-Moreno, Francisco E. Basulto-López, Carolina Salinas-Oviedo

Revista Mexicana de Neurociencia · 2020

DOI: 10.24875/rmn.19000014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Mexicana de Neurociencia, 2020. Verfasst von Ángel Solana-Rojas und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Guillain-Barré syndrome (GBS) is an acute demyelinating polyradiculoneuropathy, of autoimmune origin, with heterogeneous clinical variants. It is the most frequent cause of flaccid paralysis in children. Incidence of 0.38-0.91 cases per 100,000, rare in children under 2 years.

Objective

The objective of the study was to describe the clinical severity and complications in pediatric patients aged 1-18 years with GBS.

Methods

A descriptive and retrospective analysis was carried out. We collected data from clinical files of patients of Legaria Pediatric Hospital with stellate ganglion block, period of 3 years (January 2015-December 2017).

Results

Twenty-four patients, 18 men (75%) and 6 women (25%) were included in the study. The average age of 7.33 years (range: 1-16 years). School patients were the most affected (45.8%). Nearly 62.5% had previous respiratory infection. The most frequent clinical variant was acute inflammatory demyelinating (62.5%), axonal motor syndrome (29.2%), and Miller Fisher syndrome (8.3%). Nearly 16.7% presented dysautonomies requiring mechanical ventilation. Nearly 50% presented albuminocytological dissociation. The most frequent degree of clinical severity at admission was Grade IV on the Hughes scale (54.2%). The degree of clinical severity most frequent at discharge was Grade II on the Hughes scale (33.3%). Only 41.7% of patients received treatment with intravenous immunoglobulin (IVIG) at 1 g/kg/dia for 2 days.

Conclusions

By means of contingency tables, the association between degree of severity at admission and discharge of GBS with respect to treatment with IVIG was determined. There is a 3.8 times greater risk of severity in patients without receiving the ideal treatment.

Zitieren

APA

Solana-Rojas, Á., García-Melo, L. M., Reyes-Varela, M. D., Díaz-Sotelo, J. F., Cruz-Sánchez, A., Pérez-Moreno, J. C., Basulto-López, F. E., & Salinas-Oviedo, C. (2020). Clinical severity and associated complications in pediatric patients with Guillain-Barré syndrome. Revista Mexicana de Neurociencia. https://doi.org/10.24875/rmn.19000014

Vancouver

Solana-Rojas Á, García-Melo LM, Reyes-Varela MD, Díaz-Sotelo JF, Cruz-Sánchez A, Pérez-Moreno JC, et al. Clinical severity and associated complications in pediatric patients with Guillain-Barré syndrome. Revista Mexicana de Neurociencia. 2020. doi:10.24875/rmn.19000014

BibTeX
@article{SolanaRojas2020,
  author = {Solana-Rojas, Ángel and García-Melo, Luis M. and Reyes-Varela, María D. and Díaz-Sotelo, Juan F. and Cruz-Sánchez, Alfredo and Pérez-Moreno, Juan C. and Basulto-López, Francisco E. and Salinas-Oviedo, Carolina},
  title = {Clinical severity and associated complications in pediatric patients with Guillain-Barré syndrome},
  journal = {Revista Mexicana de Neurociencia},
  year = {2020},
  doi = {10.24875/rmn.19000014}
}
Kostenlos starten →